Crotty Robert
Insider CIK 1600253 · DNDN VP, Interim General Counsel · NBRV General Counsel & Secretary · NBRV General Counsel & Corp Secreta
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-08-31 | 2021-09-02 | 37 | $1.06 | $39 | 41,194 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-08-06 | 2021-08-10 | 74 | $1.17 | $87 | 41,231 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-07-31 | 2021-08-03 | 37 | $1.10 | $41 | 41,305 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-07-06 | 2021-07-08 | 74 | $1.27 | $94 | 41,342 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-06-30 | 2021-07-02 | 37 | $1.35 | $50 | 41,416 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-06-06 | 2021-06-08 | 73 | $1.34 | $98 | 41,453 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-05-31 | 2021-06-02 | 37 | $1.38 | $51 | 41,526 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-05-06 | 2021-05-10 | 74 | $1.49 | $110 | 41,563 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-04-30 | 2021-05-04 | 37 | $1.78 | $66 | 41,637 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-04-06 | 2021-04-08 | 74 | $1.73 | $128 | 41,674 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-03-31 | 2021-04-02 | 37 | $1.66 | $61 | 42,689 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-03-06 | 2021-04-08 | 71 | $1.79 | $127 | 41,748 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-02-28 | 2021-03-02 | 38 | $2.39 | $91 | 42,726 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-02-06 | 2021-04-08 | 870 | $2.90 | $2.5K | 41,819 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-01-31 | 2021-02-02 | 43 | $2.62 | $113 | 42,764 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2021-01-29 | 2021-02-02 | 22,500 | — | $0 | 42,807 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-12-31 | 2021-01-05 | 37 | $2.42 | $90 | 20,307 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-11-30 | 2020-12-01 | 368 | $0.43 | $158 | 203,444 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-10-31 | 2020-11-02 | 366 | $0.50 | $183 | 203,812 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-09-30 | 2020-10-01 | 366 | $0.53 | $194 | 204,178 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-08-31 | 2020-09-02 | 366 | $0.62 | $227 | 204,544 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-08-20 | 2020-08-21 | 3,759 | $0.65 | $2.4K | 204,910 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2020-08-19 | 2020-08-21 | 11,250 | — | $0 | 0 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise | 2020-08-19 | 2020-08-21 | 11,250 | — | $0 | 208,669 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-07-31 | 2020-08-04 | 366 | $0.76 | $278 | 197,419 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-06-30 | 2020-07-02 | 366 | $0.67 | $245 | 197,785 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-05-31 | 2020-06-03 | 366 | $1.14 | $417 | 198,151 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-04-30 | 2020-05-04 | 366 | $0.55 | $201 | 198,517 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-03-31 | 2020-04-02 | 366 | $0.58 | $212 | 198,883 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-02-28 | 2020-03-03 | 366 | $1.35 | $494 | 199,276 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2020-02-06 | 2020-02-10 | 210,000 | — | $0 | 210,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2020-02-06 | 2020-02-10 | 105,000 | — | $0 | 188,097 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-01-31 | 2020-02-04 | 3,892 | $1.35 | $5.3K | 83,097 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2019-08-21 | 2019-08-21 | 3,797 | $2.08 | $7.9K | 23,239 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2019-08-21 | 2019-08-26 | 3,797 | $2.08 | $7.9K | 23,239 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2019-08-19 | 2019-08-21 | 11,250 | — | $0 | 11,250 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise | 2019-08-19 | 2019-08-21 | 11,250 | — | $0 | 27,036 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2019-01-31 | 2019-02-04 | 52,500 | — | $0 | 52,500 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2019-01-31 | 2019-02-04 | 138,200 | — | $0 | 138,200 | SEC↗ |
| NBRV Nabriva Therapeutics plc | P Buy | 2018-05-23 | 2018-05-23 | 10,000 | $4.48 | $44.8K | 10,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-01-31 | 2018-02-02 | 22,500 | — | $0 | 22,500 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-01-31 | 2018-02-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | A Award deriv | 2017-06-30 | 2017-07-05 | 90,000 | — | $0 | 90,000 | SEC↗ |
| DNDNQ DENDREON CORP | S Sale | 2015-02-17 | 2015-02-18 | 21,764 | $0.08 | $1.7K | 97,855 | SEC↗ |
| DNDNQ DENDREON CORP | F Tax w/h | 2015-01-31 | 2015-02-02 | 470 | $0.16 | $75 | 119,619 | SEC↗ |
| DNDNQ DENDREON CORP | F Tax w/h | 2014-11-30 | 2014-12-02 | 912 | $0.14 | $128 | 120,089 | SEC↗ |
| DNDN DENDREON CORP | F Tax w/h | 2014-10-31 | 2014-11-03 | 472 | $0.98 | $463 | 121,001 | SEC↗ |
| DNDN DENDREON CORP | F Tax w/h | 2014-08-31 | 2014-09-03 | 912 | $1.36 | $1.2K | 121,473 | SEC↗ |
| DNDN DENDREON CORP | F Tax w/h | 2014-07-31 | 2014-08-04 | 472 | $2.07 | $977 | 122,385 | SEC↗ |
| DNDN DENDREON CORP | F Tax w/h | 2014-05-31 | 2014-06-03 | 912 | $2.16 | $2.0K | 122,857 | SEC↗ |
| DNDN DENDREON CORP | F Tax w/h | 2014-04-30 | 2014-05-01 | 459 | $2.58 | $1.2K | 123,769 | SEC↗ |
| DNDN DENDREON CORP | F Tax w/h | 2014-02-28 | 2014-03-04 | 3,955 | $2.88 | $11.4K | 124,228 | SEC↗ |
| DNDN DENDREON CORP | A Award | 2014-02-28 | 2014-03-04 | 60,000 | — | $0 | 128,183 | SEC↗ |